Newscast cover image

Weighing Up Diet Drugs

Newscast

00:00

Semaglutide: From Diabetes Treatment to Weight Loss Wonder Drug

The chapter explores the drug Semaglutide, highlighting its potential 20% reduction in heart attack or stroke risk. It delves into its journey from a diabetes treatment to a popular weight loss drug, discussing the regulatory challenges in prescribing such medications in the UK NHS. The chapter also addresses concerns around prescribing drugs outside of licenses and the skepticism surrounding a study funded by Novo Nordisk, emphasizing the importance of further research for validation.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app